Nasal High‐Flow Therapy for Infants With Bronchiolitis Across Australia and New Zealand: A <scp>PREDICT</scp> and <scp>CIRCAN</scp> Clinician Survey
Substantial variability exists in the clinical application of NHF therapy for infants with bronchiolitis, particularly in cases of moderate illness without hypoxia. Clearer clinical guidelines and better evidence for NHF in non-hypoxic infants may reduce this variability.
Authors
- Stuart R. Dalziel (ORCID: https://orcid.org/0000-0003-0522-9579)
- Simon S. Craig (ORCID: https://orcid.org/0000-0003-2594-1643)
- Donna Franklin (ORCID: https://orcid.org/0000-0003-1650-3270)
- Sharon O’Brien (ORCID: https://orcid.org/0000-0003-4864-5986)
- Shane S. George (ORCID: https://orcid.org/0000-0002-8880-1245)
- Jasmina Felsinger (ORCID: https://orcid.org/0009-0009-2389-5082)
- Lauren Shumack
Institutions
- Griffith University (AU)
- University of Auckland (NZ)
- The University of Queensland (AU)
- The University of Western Australia (AU)
- Royal North Shore Hospital (AU)
- Gold Coast Hospital (AU)
- Princess Margaret Hospital for Children (AU)
- Monash Medical Centre (AU)
- Auckland District Health Board (NZ)
- Starship Children's Health (NZ)
- Institute for Respiratory Health (AU)
- Murdoch Children's Research Institute (AU)
- Monash University (AU)
Publication Details
- Journal
- Journal of Paediatrics and Child Health
- Published
- 2025-12-20
- DOI
- https://doi.org/10.1111/jpc.70270
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fiona Stanley Hospital